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Nicotinamide mononucleotide 
(NMN) supplementation 
ameliorates the impact of maternal 
obesity in mice: comparison with 
exercise
Golam Mezbah Uddin1, Neil A. Youngson1, Bronte M. Doyle1, David A. Sinclair1,2 &  
Margaret J. Morris1
Maternal overnutrition increases the risk of long-term metabolic dysfunction in offspring. Exercise 
improves metabolism partly by upregulating mitochondrial biogenesis or function, via increased 
levels of nicotinamide adenine dinucleotide (NAD+). We have shown that the NAD+ precursor, 
nicotinamide mononucleotide (NMN) can reverse some of the negative consequences of high fat diet 
(HFD) consumption. To investigate whether NMN can impact developmentally-set metabolic deficits, 
we compared treadmill exercise and NMN injection in offspring of obese mothers. Five week old lean 
and obese female C57BL6/J mice were mated with chow fed males. Female offspring weaned onto 
HFD were given treadmill exercise for 9 weeks, or NMN injection daily for 18 days. Maternal obesity 
programmed increased adiposity and liver triglycerides, with decreased glucose tolerance, liver NAD+ 
levels and citrate synthase activity in offspring. Both interventions reduced adiposity, and showed 
a modest improvement in glucose tolerance and improved markers of mitochondrial function. NMN 
appeared to have stronger effects on liver fat catabolism (Hadh) and synthesis (Fasn) than exercise. 
The interventions appeared to exert the most global benefit in mice that were most metabolically 
challenged (HFD-consuming offspring of obese mothers). This work encourages further study to confirm 
the suitability of NMN for use in reversing metabolic dysfunction linked to programming by maternal 
obesity.
Over the last three decades, globally, the proportion of adults with a body mass index of >25 has increased to 
approximately 37% and 38% in men and women respectively1. It has also been reported that females are more 
likely to be obese or overweight than males2. Epidemiological studies have revealed associations between 
increased maternal obesity and increased infant birth weight3, adiposity4, and increased risk of offspring devel-
oping obesity in later life5. There are multiple explanations for these associations such as the shared environment 
(e.g. diet) and genetics of parent and child6, however, a key contributor is the alteration of developmental and 
metabolic processes in offspring in early life through ‘developmental’ or ‘gestational programming’6–8. These alter-
ations in glucose and fat metabolism, and appetite regulation can predispose offspring to obesity in adolescence or 
adulthood6–8. Childhood obesity itself has been shown to increase the risk for development of later life metabolic 
disorders including type 2 diabetes, cardiovascular diseases, hypertension and non-alcoholic fatty liver disease9,10. 
The process by which maternal obesity raises the risk for female offspring becoming obese, in turn perpetuating 
the risk to the next generation, has become known as the intergenerational cycle of obesity11. To reduce the risk 
for future generations, investigating interventions that can break the cycle in females are especially important.
Due to the dramatic increase in obesity in children, prevention of childhood obesity is becoming a principal 
target12. In animal models recent studies have shown that lifestyle interventions involving dieting, exercise or the 
combination of both in the mother can successfully reduce body weight13,14, triglyceride accumulation, glucose 
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intolerance and insulin resistance15,16 in offspring. Furthermore exercise during gestation can protect against 
hepatic steatosis and glucose intolerance in offspring of obese mothers14,17. Data from studies investigating phar-
macological therapies in obese mothers, including conjugated linoleic acid18, metformin19, and resveratrol20 has 
shown quite successful outcomes for offspring. However, as interventions in the mother can be problematic, there 
is still a need for interventions in the offspring themselves. In this regard our lab previously showed that the neg-
ative metabolic impacts of maternal obesity could be partially rescued by late onset (11 week of age) exercise, or 
a healthy diet, in female rat offspring21.
Mitochondria as central mediators of cellular energy metabolism, play a critical role in the pathophysiol-
ogy of obesity, and in the drug or exercise interventions mentioned above. Mitochondrial dysfunction and low 
energy (low ATP) production are found in obesity-related diseases such as insulin resistance and type 2 diabetes 
(T2D)22–25. In obesity and T2D, nicotinamide adenine dinucleotide (NAD+), an essential metabolic cofactor, is 
reduced26–28. Interconversion of NAD+ to NADH in the TCA cycle, β-oxidation and oxidative phosphorylation is 
crucial for mitochondrial metabolism and with age, NAD+ levels can decline by up to 50%29.
In animals, physical activity has been shown to improve mitochondrial biogenesis and function as well as 
increase the levels of NAD+ in primary metabolic organs30–32. Indeed, it is thought that many of the benefits of 
exercise and of fasting stem from increasing NAD+, which stimulates mitochondrial function leading to burning 
of fat and carbohydrate stores33,34.
In mammals, NAD is synthesised from tryptophan or recycled from nicotinamide via the salvage pathway 
through an intermediate nicotinamide mononucleotide (NMN). The NAD+ precursors, NMN and NR, are ther-
apeutic targets for treating metabolic disorders and aging35. Studies including our own on mice have shown that 
NMN supplementation increases NAD+ levels, improves glucose clearance in HFD induced obesity, aging and 
diabetes26,27,33. However, while there is extensive overlap in the ultimate physiological effects of diet-induced and 
developmentally-programmed metabolic disease there are significant differences. Diet-induced obesity is related 
to increased ingestion of energy in childhood or adulthood. In contrast, effects of maternal obesity such as adi-
posity4 are evident at birth and involve alterations to oocyte state36,37 and the gestational milieu7. Therefore, while 
previous studies by us and others have shown the ability of NMN-supplementation to reduce liver fat content in 
mouse models of diet-induced obesity, it is unknown whether this intervention is effective at reversing metabolic 
deficits that are initiated prior to birth. We hypothesised that the benefits of NMN would be particularly pro-
nounced in offspring liver, and would be linked to changes in fat metabolism.
Here we aimed to test whether NMN administration could ameliorate the effects of maternal obesity in female 
offspring consuming either regular or HFD post-weaning. The other major goal of this experiment was to con-
trast the effects of exercise and NMN in these female offspring. To do so, we examined effects on weight gain, 
adiposity and glucose tolerance, and measured mitochondrial DNA copy number as a marker of mitochondrial 
number, triglyceride as a marker of fat storage in the liver, and liver NAD+ and NADH levels. As a mitochondrial 
functional marker we chose the widely utilised citrate synthase activity. We also investigated the mRNA level of 
fat metabolism markers in liver.
Methods and Materials
Animal procedures. All animal experimental protocols were approved by the Animal Ethics Committee, 
UNSW, and carried out according to their guidelines and regulations (ethics number 13/25B). Three week old 
C56BL6/J female mice (n = 128, Animal Resources Centre, Perth) were housed at the Biological Resources Centre 
facility, UNSW, Australia. Mice were acclimatised for a week on standard chow diet. Then groups of mice of 
similar average body weight were assigned to either control chow (n = 48) or HFD (n = 80). HFD pellets were a 
semi-pure formulation for laboratory rats and mice based on Research Diets D12451 from Specialty Feeds, Glen 
Forrest, WA, Australia (23.5% of total weight is fat and 19MJ/kg digestible energy, SF 04-001). After 5 weeks on 
the different diets, 1 male adult chow-fed mouse was introduced to each cage of 4 females for 7 days. There was no 
significant difference in body weights of stud mice between dietary groups. Fourteen days after mating pregnant 
mice were housed individually; prepregnancy diet was continued throughout pregnancy and lactation. Pups were 
born over a 3 day period, and were left undisturbed for the first week to prevent maternal stress. At PND 24 female 
offspring were weaned, and distributed across chow or HFD groups, ensuring similar starting body weights. 
Mothers were sacrificed and tissue collected from metabolic organs after weaning. The experimental timeline is 
presented in Supplementary Fig. S1.
After 6 weeks of post-weaning diet, offspring from HFD fed mothers were further distributed into either 
sedentary, exercise, or NMN groups thus generating 6 groups: HFD-Chow-sedentary HCS; HFD-Chow-exercise 
HCX; HFD-Chow-NMN HCN; HFD-HFD-sedentary HHS; HFD-HFD-exercise HHX; HFD-HFD-NMN 
HHN (Supplementary Fig. S1). Offspring from chow mothers remained in their chow or HFD groups: 
Chow-Chow-sedentary: CCS; Chow-HFD-sedentary: CHS. At 9 weeks of age, treadmill running began in those 
offspring of obese mothers assigned to exercise as described below, and from 18 days before cull NMN or vehicle 
was provided.
After 5 days of training, HCX and HHX mice underwent treadmill (Columbus Instruments Exer 3/6 (0257-
901 M)) running 6 days (55 min/day) per week for 9 weeks. In each session the exercised mice had a warm-up 
period of increasing running speed from 6 to 12 m/min. At 9 min the speed was increased to 15 m/min. In each 
session after 400 m, the speed was slowed to 6 m/min for 5 minutes then returned to 15 m/min for another 
20 minutes. Exercise was carried out an hour before the end of the light period (1700–1830 hrs). All mice in the 
non-exercise groups experienced the treadmill with the belt turned off, 5 days a week. NMN was dissolved in PBS 
and injected i.p. daily for 18 days before sacrifice, 500 mg/kg body weight26,27. All non-NMN treated mice received 
a vehicle i.p. injection of PBS daily at the end of the light period.
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Glucose tolerance test (GTT). At 17 weeks of age mice were fasted for 5 hours prior to the GTT. Baseline 
blood glucose was measured by tail nick at time 0. Mice were then challenged with an i.p. glucose bolus (2 g/kg 
body weight). Blood glucose was measured using Accu-ChekH glucose meter (Roche Diagnostics).
Sample collection, processing and plasma insulin concentration. At 19 weeks NMN or vehicle 
was injected 4 hours before anaesthetic. Mice were culled starting at 1200 h the next day and the exercise groups 
had their final session the day before cull. Animals were weighed and fasted for 5 hours then mice were anes-
thetized (ketamine/xylazine 200/20 mg/kg, i.p.). A blood sample was collected by cardiac puncture and plasma 
collected after centrifugation (2000 g 10 mins). Plasma insulin concentrations were measured by Ultra-Sensitive 
Mouse Insulin ELISA kit (Crystal Chem Inc.). After decapitation, white adipose tissue (gonadal, retroperitoneal, 
inguinal), muscle (quadriceps, tibialis, soleus) and liver were weighed. Liver was ground using a tissue pulverizer 
(Bessman) on dry ice and liquid N2.
Hepatic triglyceride, citrate synthase activity and NAD+-NADH assays. Triglyceride measure-
ment was conducted as described previously26. Briefly, after homogenisation and extraction, liver triglyceride 
content was determined using a commercially available colorimetric assay kit, TG reagent Triglyceride GPO-PAP 
(cat# 11730711 216) from Roche/Hitachi. After incubation samples were read on a BioRad iMark plate reader.
Citrate synthase activity was assayed by homogenizing 35 mg of powdered liver in tris buffer and subjecting 
to three freeze-thaw cycles with liquid N226. Data were standardised for protein content, quantified using Bovine 
Serum Albumin (BSA) as standard (ThermoFisher Scientific Cat#23208)
Levels of NAD+ and its reduced form NADH were measured as described26,38. Homogenised samples were 
extracted for protein and NAD measurements. Total NAD and NAD+ were quantified using a Bio-Rad Imark 
microplate reader; data are presented as picomoles of NAD+ or NADH per mg of protein.
Mitochondrial DNA copy number and quantitative RT-PCR. Mitochondrial DNA copy number 
was measured by qPCR as previousy described26. DNA was extracted from 25–30 mg of ground liver. SYBR 
green Qpcr (SensiFAST SYBR, Bioline) was used to determine mitochondrial DNA copy number. Two primers 
were used, 36B4 for the nuclear genome (amplifies a region of the Rplp0 gene) and Cytb for the mitochondrial 
genome26.
RNA was extracted using Tri-reagent (Sigma, St. Louis, MO, USA), and quantified by Biospec-nano spectro-
photometer (Shimadzu Biotech, Nakagyo-ku, Kyoto, Japan). After TRI-reagent extraction ~2 μG of RNA from 
each sample was visualised on an agarose gel. Only samples with clear 18 S and 28 S rRNA bands (thus confirming 
that the RNA had minimal degradation) were used for subsequent RT-qPCR analysis.
Expression of target genes was measured using a Roche LightCycler480. Standard curves were produced for 
each gene using templates generated by serial dilution of a combined cDNA sample from all samples.
All sample PCRs were done in duplicate, and all genes of interest were normalized by dividing by the geomet-
ric mean of two control genes Gapdh and Ywhaz. No difference in expression of housekeeper genes was observed 
across treatment groups. All primer sequences are shown in Supplementary Table S4. qPCR relative fold changes 
between groups are presented with the CCS group given the value 1.
Statistical analysis. Data are expressed as mean ± SEM. Body weight and GTT were analysed by 3-way 
mixed ANOVA. Body weight and GTT of offspring of obese mother were separately analysed based on 
post-weaning diet using repeated one-way ANOVA. Due to logistical constraints the design necessitated separate 
2-way ANOVA analyses for all other parameters. Thus the effect of maternal and post-weaning diets using the 
CCS, CHS, HCS and HHS groups, and the effect of the interventions and post-weaning diets using the HCS, 
HCX, HCN, HHS, HHX and HHN groups used separate 2-way ANOVAs. If data were not normally distributed 
they were log transformed to achieve normality before analyse. Significant differences at P < 0.05 level between 
diet groups are shown as † overall maternal HFD effect; * overall post-weaning HFD effect. For interventions, 
# overall intervention effect; X simple main effect of exercise; ^ simple main effect of NMN.
Results
Effect of HFD on dams and mating outcome. At four weeks of age, female mice with an average body 
weight of 13.11 ± 0.09 g were separated into either chow or HFD groups. A week later mice fed with chow were 
14.45 ± 0.18 g whereas HFD fed mice weighed 16.54 ± 0.14 g. At nine weeks of age, before mating, HFD mice were 
20% heavier than chow (21.22 ± 0.37 versus 17.58 ± 0.25 g, P < 0.001). Pregnancy rates were similar in chow and 
HFD-fed females. There were no differences in litter size or offspring sex ratio between the dietary groups (data 
not shown). At weaning offspring were allocated to different diet groups, ensuring no significant differences in 
average starting body weights. All groups were sourced from 9–11 different mothers.
To characterise the effects of the HFD on the mothers we sacrificed 16 mice (8 from each diet group) a week 
after the offspring were weaned. Examination of tissue weights showed significant increases in heart, quadriceps 
muscle and gonadal fat mass (Supplementary Table S2). After normalisation as % body weight, we found signif-
icantly higher gonadal fat accumulation in HFD fed mothers compared to chow fed mice. As expected the basal 
glucose concentration was significantly higher compared to chow fed mothers (Supplementary Table S2).
Diet and intervention effects on body weight of female offspring. Maternal HFD had a significant 
impact on pup body weight (F(1,52) = 54.122, p < 0.001, Fig. 1A) whereby pups from mothers consuming HFD 
were heavier than those from lean mothers. The impact of maternal obesity was exacerbated if pups went on to 
HFD (F(1,52) = 11.914, p < 0.001) Fig. 1A. At 19 weeks the post-weaning HFD impact was greater in those from 
obese mothers (44% heavier) than lean mothers (15% heavier than controls) (Table 1).
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At 9 weeks of age chow or HFD fed offspring from HFD mothers were further distributed into sub groups: seden-
tary, exercise and NMN. Note, at this time-point NMN was not yet implemented. At 14 and 15 weeks of age exercise was 
associated with body weight reductions both in mice consuming chow (p < 0.05) and HFD (p < 0.05) (Fig. 1B and C). 
At 19 weeks NMN had reduced body weight in both the chow fed and HFD groups (P < 0.05) (Table 2).
Diet effects on organ mass of female offspring. To investigate impacts of maternal diet and 
post-weaning diet, various tissues were collected. Both maternal obesity and HFD consumption increased adi-
posity (Table 1). When tissue weight was standardised as % body weight, a significant maternal HFD effect was 
observed in liver, gonadal and retroperitoneal fat. A post-weaning diet effect was apparent in liver, quadricep and 
anterior tibialis muscles, gonadal, inguinal, and retroperitoneal fat, which were all increased (Table 2).
Effect of post-weaning diet, exercise and NMN on tissue phenotypes. Mass of all three fat pads– 
gonadal, inguinal and retroperitoneal were significantly reduced by the interventions. No significant changes were 
induced in muscle or liver mass by the exercise and NMN interventions. A post-weaning HFD increased the mass of all 
three muscles and fat pads (Table 2), with no effect on liver weight. When the tissue weights were normalised to % body 
weight, a main effect of post weaning diet was observed in quadricep and AT muscle and all three fat pads as well as liver.
Glucose tolerance and basal insulin. Both maternal (F(1,44) = 14.768, p < 0.001) and post-weaning 
(F(1,44) = 108.719, p < 0.001) diet had significant impacts on plasma glucose clearance suggesting that offspring 
from obese mothers were less glucose tolerant (Fig. 1D). As expected offspring consuming HFD were significantly 
glucose intolerant relative to those consuming chow, regardless of their mothers diet. The area under the GTT 
curve presented in Fig. 1E shows significant effects of maternal (F(1,48) = 18.8, p < 0.001) and post-weaning diet 
(F(1,48) = 115.7, p < 0.001).
Figure 1. Diet and intervention effects on body weight and GTT of female offspring. Data are shown as 
mean ± SEM, n = 11–16 per group. The first letter represents the maternal diet and the second letter post-
weaning diet; chow (C) or HFD (H); the third letter represents intervention; sedentary (S), exercise (X) or NMN 
(N). Abbreviations: GTT, Glucose tolerance test; AUC, Area under curve. To explore the impact of maternal 
and post-weaning diet on body weight and GTT in the sedentary offspring groups CCS (open circle dotted 
line), CHS (closed circle dotted line), HCS (open circle solid line) and HHS (closed circle solid line) were 
analysed by three-way mixed ANOVA (A,D). To explore the impact of exercise or NMN on body weight over 
time, separate repeated one-way ANOVAs were performed in the offspring of obese mothers that consumed 
chow (B) or HFD (C). A separate two-way ANOVA was performed to analyse the AUC in these animals (E). 
To explore the impact of interventions (exercise and NMN) on GTT in the offspring consuming chow (F) and 
HFD (G), separate repeated one-way ANOVAs were performed. The significant effects are: †P < 0.05, ††P < 0.01, 
†††P < 0.001 overall maternal HFD effect. ***P < 0.001 overall post-weaning diet effect. XP < 0.05, XXP < 0.01, 
XXXP < 0.001 simple main effect of exercise. ^P < 0.05, ^^^P < 0.001 simple main effect of NMN.
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No significant effect of intervention was observed in offspring consuming chow (Fig. 1F). In siblings consum-
ing HFD, exercise and NMN improved the late phase of the response to glucose challenge (Fig. 1G). Measurement 
of the area under the curve (not shown) suggested that there are beneficial effects of both interventions. However 
only exercise reached significance (HHS vs HHEX P = 0.009; HHS vs HHN P = 0.059).
Both maternal and post-weaning diet had significant impacts on plasma insulin. Maternal and post weaning 
HFD increased plasma insulin concentration (Table 1). Furthermore, NMN significantly increased insulin con-
centration regardless of their diet (Table 2).
NAD+ and NADH levels in liver. While maternal diet had no effects, post-weaning HFD reduced NAD+ 
levels (F(1,16) = 17.599, p = 0.001) (Fig. 2A). There were no effects of post-weaning or maternal diet on concen-
trations of the reduced form, NADH (Fig. 2C). Interventions increased NAD+ concentrations in the offspring 
from obese mothers (F(1,24) = 36.306, p < 0.001, Fig. 2B). A significant increase in NADH concentrations was 
also seen with NMN treatment (F(1,24) = 15.681, p < 0.001, Fig. 2D), in line with the increased NAD+ concen-
trations. Exercise had no impact on NADH concentrations. Post-weaning HFD consumption was associated with 
significant increases in NADH (F(1,24) = 4.7, p < 0.05). Overall, there was a detrimental impact of post-weaning 
HFD on NAD+ concentrations, an increase with NMN treatment, with a more modest impact of exercise.
Liver citrate synthase activity. Both maternal (F (1,34) = 3.9, p = 0.054) and post weaning (F(1,34) = 11.496, 
p < 0.01) diet reduced citrate synthase activity, but there was no additive effect (Fig. 2E). NMN treatment, but not 
exercise, increased citrate synthase activity in HFD consuming offspring (F(1,52) = 4.4, p < 0.01, Fig. 2F).
Liver and plasma triglycerides. Liver triglyceride content shows an interesting graded response whereby 
both maternal (F (1,36) = 21.118, p < 0.001) and post-weaning (F(1,36) = 29.845, p < 0.001) HFD led to increased 
fat storage. The combination of maternal and post-weaning HFD led to an approximate doubling of hepatic 
triglyceride content compared to CCS (Fig. 2G). Offspring consuming HFD showed a significant reduction in 
hepatic triglyceride accumulation in response to both interventions; exercise and NMN (Fig. 2H).
Post-weaning HFD significantly increased plasma triglyceride with no maternal diet effect (Table 1). Neither 
intervention significantly altered plasma triglyceride concentration (Table 2).
Maternal and post weaning diet affected expression of genes related to fat metabolism and 
gluconeogenesis. A range of genes involved in fat metabolism and gluconeogenesis were investigated for 
effects of maternal and post-weaning diet on their mRNA expression across CCS, CHS, HCS and HHS groups 
(Table 3). Cd36, a marker for fat transport into liver, showed higher mRNA expression in the liver in response to 
both maternal and post-weaning HFD. A significant effect of maternal HFD on Pparg mRNA expression, suggest-
ing that maternal HFD was associated with increased fatty acid storage, where post-weaning HFD exacerbated 
the condition. Expression of Fasn mRNA was significantly decreased by post-weaning HFD consumption. Acetyl 
CoA carboxylase (Acc1) was higher in offspring from obese mothers and from lean mothers when offspring 
were consuming HFD. Mitochondrial pyruvate carrier Mpc1 is responsible for transporting pyruvate out of the 
mitochondria for gluconeogenesis. Here, maternal and post-weaning HFD both increased Mpc1 expression sug-
gesting increased capacity for gluconeogenesis. Increases due to offspring HFD, but not maternal HFD were also 
seen in Pyruvate carboxylase (PC) and Phosphoenolpyruvate carboxykinase (Pck1) which are other genes that 
Overall Effects
CCS CHS HCS HHS Maternal diet Post Weaning Diet Interaction
Final BW (g) 18.1 ± 0.2 20.9 ± 0.1*** 19.5 ± 0.3 28.04 ± 1.2†††/*** F(1,52) = 62.33,P < 0.001 F(1,52) = 110.37, P < 0.001 F(1,52) = 27.24, P < 0.001
Liver (mg) 765 ± 14 693 ± 13* 779 ± 43 852 ± 27††† F(1,48) = 11.9, P < 0.001 ns F(1,48) = 8.4, P < 0.01
Muscle (mg)
Quad 236 ± 10 256 ± 11 247 ± 10 295 ± 8 F(1,50) = 5.7, P < 0.05 ns
AT 82 ± 4 88 ± 3 87 ± 3 98 ± 5 F(1,52) = 4.2, P < 0.05 F(1,52) = 4.9, p < 0.05 ns
Soleus 12.4 ± 0.7 15.9 ± 0.7 15.1 ± 0.7 19.6 ± 0.6 F(1,51) = 21.6, P < 0.001 F(1,51) = 34.7, p < 0.001 ns
WAT (mg)
Gonadal 141 ± 8 601 ± 89*** 231 ± 22 1348 ± 164†††/*** F(1,51) = 22.3, P < 0.001 F(1,51) = 79.1, P < 0.001 F(1,51) = 13.7, P < 0.001
Inguinal 165 ± 11 463 ± 57*** 207 ± 13 823 ± 108†††/*** F(1,49) = 12.4, P < 0.001 F(1,49) = 63.7, P < 0.001 F(1,49) = 7.7, P < 0.01
RP 26.1 ± 2.3 143.0 ± 25.2*** 44.5 ± 4.2 347.5 ± 33.5†††/*** F(1,52) = 29.9, P < 0.001 F(1,52) = 106.5, P < 0.001 F(1,52) = 20.9, P < 0.001
Plasma Insulin (ng/mL) 0.085 ± 0.020 0.154 ± 0.016*** 0.166 ± 0.020 0.420 ± 0.0.038†††/*** F(1,32) = 38.2, P < 0.001 F(1,32) = 33.2, P < 0.001 F(1,32) = 10.9, P < 0.01
Plasma Triglycerides (mg/mL) 2.82 ± 0.24 3.21 ± 0.16** 2.94 ± 0.11 3.62 ± 0.22** ns F(1,36) = 7.8, P < 0.01 ns
Table 1. Body weight and organ mass in offspring of lean and obese mothers that consumed chow or HFD 
post-weaning Data are shown as mean ± SEM, n = 11–16 per group. The first letter indicates maternal 
HFD, chow (C) or HFD (H); second letter indicates post-weaning diet (C or H); the third letter represents 
intervention; sedentary (S). To explore the impact of maternal and post-weaning diet on body weight and tissue 
phenotypes in the sedentary offspring groups CCS, CHS, HCS and HHS were analysed by two-way mixed 
ANOVA. Abbreviations: BW, body weight; WAT, white adipose tissue. Main effects are presented in the right 
hand panel. The significant effects are: †††P < 0.001 overall maternal HFD effect. *P < 0.05, ***P < 0.001 overall 
post-weaning diet effect. ns, no significant difference.
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function in the early stages of gluconeogenesis. However, no effects were seen in the mRNA levels of the gene that 
is responsible for the terminal step of the process, Glucose-6-phosphatase (G6pc).
Offspring diet and interventions affected expression of genes related to fat metabolism and 
gluconeogenesis. Gene expression in female offspring from obese mothers are depicted in Fig. 3. The effect 
of maternal HFD to increase Cd36 and Fasn seen in Table 3 was reduced by both interventions (Fig. 3A,B). NMN 
reduced the mRNA expression of Fasn significantly, compared to vehicle control in both diets. A significant effect 
of post-weaning diet (F(1,51) = 36.9, p < 0.001) suggests that there is also a HFD effect to decrease expression of 
Fasn (Fig. 3B). There are two subunits of acetyl-CoA carboxylase, Acc1 and Acc2 (responsible for fatty acid syn-
thesis and production of malonyl CoA). Both exercise (P < 0.001) and NMN (P < 0.01) reduced Acc1 expression 
only when pups consumed HFD (Fig. 3C). Both interventions exerted similar effects on Acc2 gene expression 
(Fig. 3D). Mpc1 (Fig. 3E) and Pparg (Fig. 3F) mRNA expression were significantly reduced by NMN treatment 
in mice from obese mother consuming either chow or HFD. A significant increase of Hadh mRNA was induced 
by NMN only when offspring consumed HFD post-weaning (Fig. 3G). Analysis revealed a significant effect of 
post-weaning diet on Hadh mRNA expression, F(1,52) = 15.086, p < 0.001), which suggests a possible increase 
in β-oxidation in liver. However, there were no changes observed in Cpt1 mRNA expression (Supplementary 
Fig. S3). The effect of the interventions on liver gluconeogenesis was less clear than on fat metabolism in that 
organ. Both NMN and exercise significantly reduced Mpc1 transcript levels which may suggest reduced glucone-
ogenesis (Supplementary Fig. S3). However, no significant intervention effects were seen in other markers.
No changes in hepatic Sirt1 mRNA expression were observed in response to post-weaning diet or either inter-
vention. We found significant changes in Pgc1α mRNA expression, whereby post weaning diet reduced expres-
sion (F(1,53) = 36.7, p < 0.001). Exercise increased Pgc1α expression significantly only when pups consumed 
chow diet (Supplementary Fig. S3C). There was no maternal diet effect; however post-weaning HFD increased 
the mtDNA copy number with no significant effect of interventions.
CCS CHS HCS HCX HCN HHS HHX HHN
Final BW (g) 18.1 ± 0.2 20.9 ± 0.1 19.5 ± 0.3 18.5 ± 0.3X 18.7 ± 0.2^ 28.04 ± 1.2 24.3 ± 0.9XX 24.8 ± 0.7^
Liver (mg) 765 ± 14 693 ± 13 779 ± 43 758 ± 23 811 ± 18 852 ± 27 779 ± 26 763 ± 22
Muscle (mg)
   Quad 236 ± 10 256 ± 11 247 ± 10 254 ± 12 272 ± 6 295 ± 8 303 ± 5 304 ± 7
   AT 82 ± 4 88 ± 3 87 ± 3 86 ± 3.21 87 ± 3 98 ± 5 110 ± 4 100 ± 5
   Soleus 12.4 ± 0.7 15.9 ± 0.7 15.1 ± 0.7 15.0 ± 0.5 16.3 ± 1.1 19.6 ± 0.6 20.2 ± 0.5 19.2 ± 0.7
WAT (mg)
   Gonadal 141 ± 8 601 ± 89 231 ± 22 231 ± 14 202 ± 15 1348 ± 16 946 ± 149X 923 ± 92^
   Inguinal 165 ± 11 463 ± 57 207 ± 13 232 ± 14 196 ± 5 823 ± 108 512 ± 66XXX 532 ± 58^^
   RP 26.1 ± 2.3 143.0 ± 25.2 44.5 ± 4.2 43.1 ± 2.4 40.5 ± 2.2 347.5 ± 33.5 252.0 ± 38.2XX 220.5 ± 22.1^^^
Plasma Insulin (ng/mL) 0.085 ± 0.020 0.154 ± 0.016 0.166 ± 0.020 0.224 ± 0.037 0.317 ± 0.030^ 0.420 ± 0.0.038 0.469 ± 0.033 0.588 ± 0.064^^
Plasma Triglycerides (mg/mL) 2.82 ± 0.24 3.21 ± 0.16 2.94 ± 0.11 3.38 ± 0.23 2.31 ± 0.41 3.62 ± 0.22 3.83 ± 0.24 3.14 ± 0.26
Main effects of the ANOVA analysis of HC, HCX, HCN, HH, HHX, HHN offspring
Intervention Post Weaning Diet Interaction
Kill BW (g) F(2,64) = 6.7, P < 0.01 F(1,64) = 135.5, P < 0.001 ns
Liver (mg) ns ns ns
Muscle (mg)
Quad ns F(1,63) = 39.4, P < 0.001 ns
AT ns F(1,64) = 26.1, P < 0.001 ns
Soleus ns F(1,62) = 49.5, p < 0.001 ns
WAT (mg)
Gonadal F(1,65) = 3.1, P < 0.05 F(1,65) = 110.7, P < 0.001 ns
Inguinal F(1,62) = 3.7, P < 0.05 F(1,62) = 74.9, P < 0.001 F(1,62) = 4.3, P < 0.05
RP F(1,63) = 4.6, P < 0.05 F(1,63) = 157.3, P < 0.001 F(1,63) = 4.1, P < 0.05
Plasma Insulin (ng/mL) F(1,49) = 7.2, P < 0.01 F(1,49) = 54.7, P < 0.001 ns
Plasma Triglycerides (mg/mL) F(1,50) = 5.9, P < 0.01 F(1,50) = 9.6, P < 0.01 ns
Table 2. Body weight and organ mass in sedentary or exercised or NMN treated offspring of obese mothers 
that consumed chow or HFD post-weaning. Data are shown as mean ± SEM, n = 11–12 per group. The first 
letter indicates maternal diet, chow (C) or HFD (H); second letter indicates post-weaning diet (C or H); the 
third letter represents intervention; sedentary (S), exercise (X) or NMN (N). To explore the impact of post-
weaning diet and intervention (exercise and NMN) on body weight and tissue phenotypes, the offspring 
groups HCS, HCX, HCN and HHS, HHX, HHN were analysed by a two-way mixed ANOVA presented upper 
section of the table. Offspring from lean mothers (CCS & CHS) are shown for comparison. Abbreviations: BW, 
body weight; WAT, white adipose tissue. Overall effects are presented in the bottom section of the table. The 
significant effects are: XP < 0.05, XXP < 0.01, XXXP < 0.001 simple main effect of exercise. ^P < 0.05, ^^P < 0.01, 
^^^P < 0.001 simple main effect of NMN.
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Figure 2. Effects of maternal diet, post-weaning diet, exercise and NMN on Hepatic NAD+ - NADH, citrate 
synthase activity and triglyceride content. Data are shown as mean ± SEM, n = 5–12 per group. The first letter 
represents maternal and second letter represents post-weaning diet; chow (C) or HFD (H); the third letter 
represents intervention; sedentary (S), exercise (X) or NMN (N). To investigate the effects of maternal and 
post-weaning diets on CCS, CHS, HCS and HHS groups on NAD+ (A), NADH (C), citrate synthase activity (E) 
and triglyceride (G) contents two-way ANOVAs were performed. To investigate the effects of post-weaning diet 
and intervention (exercise and NMN) on NAD+ (B), NADH (D) citrate synthase activity (F) and triglyceride 
(H) contents of the offspring from obese mothers consuming chow or HFD, HCS, HCX, HCN and HHS, 
HHX, HHN groups were compared by two-way ANOVA. The significant effects are: †P < 0.05, ††P < 0.01 and 
†††P < 0.001 overall maternal HFD effect. **P < 0.01 and ***P < 0.001 overall post-weaning diet effect. #P < 0.05 
and ###P < 0.001 overall intervention effect. XP < 0.05 simple main effect of exercise. ^P < 0.05, ^^P < 0.01 and 
^^^P < 0.001 simple main effect of NMN.
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Discussion
The correlations between maternal body weight during pregnancy and long-term offspring health risks mean 
that there is much interest in finding effective interventions to reduce these risks. Studies in humans and animals 
have shown that strategies that increase energy utilisation either through pharmacological approaches or physi-
cal activity can be effective. Here we wanted to test whether physical exercise or NMN treatment in offspring of 
obese mothers would improve metabolism, as we have previously shown in female mice exposed to diet induced 
obesity26.
In this study, as expected, the HFD induced greater accumulation of adipose tissue in the mothers, and a 
subsequent increase in pup body weight prior to weaning. A feature of programmed phenotypes is that they 
are often latent until exposed by a second environmental factor that occurs later in life. A clear illustration of 
this is the detection or exacerbation of phenotypes due to the combined impact of maternal obesity and off-
spring eating HFD themselves39–41. In this study significant differences were observed between mice that experi-
enced the combined metabolic insult of maternal and offspring HFD (i.e. HHS) and the group that experienced 
post-weaning HFD alone (CHS). These differences were in final body weight, organ weights, GTT, plasma insu-
lin, liver triglyceride and Pparg transcript levels. In addition, comparing CCS and HCS groups revealed some 
programmed phenotypes even without the exacerbation of post-weaning HFD, specifically in liver triglyceride, 
CS activity and Mpc1, Pparg and Cd36 transcript. In all instances these programmed changes (either latent or 
manifest) were in the same direction as those caused by post-weaning HFD alone (CCS vs CHS) which suggests 
that there is a high similarity in the regulatory and physiological effects of maternal obesity and diet induced 
obesity on fat metabolism and markers of mitochondrial function in the liver. These observations are consistent 
with previous studies that investigated programming by maternal obesity21,41–43. To our knowledge we are the 
first to investigate how maternal obesity affects NAD+ concentrations. Our data support earlier reports26,27, of 
reduced NAD+ concentrations in response to post-weaning HFD consumption. There also appeared to be a 
slightly greater (non-significant) reduction in those from obese mothers, which may suggest that liver NAD+ 
metabolism is influenced by programmed processes such as those that also reduced CS activity. Further work 
is needed to understand how i.p. NMN injection leads to increased NAD+ levels in the liver. Previous work has 
shown that increases in liver NAD+ can be detected 30 minutes after oral administration of NMN44. However, 
the relative importance of the NAD+ biosynthetic and salvage pathways45 in both NMN supplementation and 
exercise requires more investigation.
Effects of NMN supplementation on hepatic fat metabolism were considerable. High levels of NAD+ are 
known to increase mitochondrial function and biogenesis46. In this study NMN led to marked increases in 
hepatic NAD+ levels, with similar impacts in offspring consuming chow or HFD. High NAD+ concentrations in 
liver following NMN supplementation may reflect the pharmacokinetics related to i.p. injection. Moreover, NMN 
was injected on the morning of tissue harvest.
Most intervention studies using the NAD+-precursor NR or the allosteric sirtuin activator resveratrol47 in 
HFD-induced obesity in mice have reported reduced body weight and fat accumulation48–50. Unlike previous 
Gene CCS CHS HCS HHS Maternal diet Post weaning diet Interaction
Acc1 1.00 ± 0.05 1.28 ± 0.07** 1.27 ± 0.09†† 1.16 ± 0.08 ns ns F (1, 34) = 7.522, p < 0.01
Acc2 1.00 ± 0.05 0.99 ± 0.04 0.97 ± 0.09 0.86 ± 0.10 ns ns ns
Cd36 1.00 ± 0.06 1.37 ± 0.08 1.48 ± 0.13 1.55 ± 0.16 F (1,33) = 8.982, p < 0.01 F(1,33) = 4.231, p < 0.05 ns
Fasn 1.00 ± 0.13 0.59 ± 0.05 0.89 ± 0.08 0.53 ± 0.03 ns F(1,31) = 23.58, p < 0.001 ns
Pgc1a 1.00 ± 0.07 0.79 ± 0.06 0.96 ± 0.02 0.85 ± 0.06 ns F(1,31) = 6.1, p < 0.05 ns
Mpc1 1.00 ± 0.07 1.45 ± 0.07 1.31 ± 0.08 1.53 ± 0.11 F (1,33) = 5.435, p < 0.05 F(1,31) = 16.285, p < 0.001 ns
PC 1.00 ± 0.07 1.32 ± 0.18 0.76 ± 0.08 0.97 ± 0.07 ns F(1,33) = 6.051, p < 0.05 ns
Pck1 1.00 ± 0.22 1.49 ± 0.23 1.00 ± 0.19 1.27 ± 0.26 ns F(1,31) = 4.710, p < 0.05 ns
G6pc 1.00 ± 0.14 1.09 ± 0.19 1.00 ± 0.18 0.99 ± 0.24 ns ns ns
Pparg 1.00 ± 0.12 0.56 ± 0.06** 1.82 ± 0.24††† 2.82 ± 0.48†††/*** F (1, 30) = 20.9, p < 0.001 F (1, 30) = 4.6, p < 0.05
Sirt1 1.00 ± 0.04 1.20 ± 0.03 0.89 ± 0.05 1.12 ± 0.09 ns ns ns
Hadh 1.00 ± 0.05 1.12 ± 0.06 1.10 ± 0.06 1.15 ± 0.07 ns ns ns
Cpt1 1.00 ± 0.06 1.01 ± 0.08 1.12 ± 0.10 1.00 ± 0.07 ns ns ns
Table 3. mRNA expression of fat metabolism and gluconeogenesis markers in offspring of lean and obese 
mothers that consumed chow or HFD post-weaning. Data are shown as mean ± SEM, n = 9–10 per group. The 
first letter indicates maternal diet, chow (C) or HFD (H); second letter indicates post-weaning diet (C or H); 
the third letter represents intervention; sedentary (S). To explore the impact of maternal and post-weaning 
diet on body weight and tissue phenotypes in the sedentary offspring groups CCS, CHS, HCS and HHS were 
analysed by two-way mixed ANOVA. Overall effects are presented in the right hand panel. Data are presented 
as fold changes compared to the CCS group. Abbreviations: Acc: Acetyl CoA Carboxylase; Cd36: Cluster of 
differentiation 36 / fatty acid translocase; Fasn: fatty acid synthase; Pparg: Peroxisome proliferator-activated 
receptor; Mpc1: mitochondrial pyruvate career; Sirt1: silent mating type information regulation; PC: Pyruvate 
carboxylase; Pck1: Phosphoenolpyruvate carboxykinase; G6pc: Glucose-6-phosphatase. The significant effects 
are: ††P < 0.01, †††P < 0.001 overall maternal HFD effect. **P < 0.01, ***P < 0.001 overall post-weaning diet effect. 
ns, no significant difference.
www.nature.com/scientificreports/
9Scientific RePoRTS | 7: 15063  | DOI:10.1038/s41598-017-14866-z
studies where no weight changes were observed in HFD fed mice with 727 or 1026 days of i.p. NMN treatment27, 
here for the first time we found a significant reduction in final body weight with a slightly longer period of NMN 
(18 days). Reductions in fat mass were observed in response to both exercise and NMN; these were more pro-
nounced in offspring consuming HFD, and they were of similar magnitude across both interventions. While it 
appeared NMN may have led to some fat loss in offspring consuming chow, this failed to reach significance.
Our findings showed increased triglyceride accumulation in response to both maternal and post weaning 
HFD. This is an indicator of major metabolic impairment. NMN supplementation partially reversed liver triglyc-
eride accumulation. Lower hepatic triglyceride levels can be related to several processes: increased fat catabolism, 
reduced fat synthesis, or reduced fat import into the liver. Our results suggest that all three processes are altered 
by NMN in ways that would reduce liver fat content. The increases in mitochondrial activity (CS activity) and 
β-oxidation (Hadh levels) would increase fat catabolism. Decreases were also seen in genes involved in fat synthe-
sis (Fasn, Acaca, Acacb) and storage (Pparg). Finally, reduced Cd36 suggests that the NMN-supplemented liver is 
importing less fatty acid.
In HHS groups the reduction in liver triglyceride was equivalent in the exercise (HHX) or NMN (HHN) 
groups. However, it is likely that there are mechanistic differences in the ways these interventions reduce liver 
triglyceride. As mentioned above NMN-supplementation led to large increases in liver NAD+ while exercise did 
not. This excess of NAD+ is expected to increase a variety of sirtuin mediated processes such as mitochondrial 
function, fatty acid synthesis and β-oxidation49,51,52. In support of this we found that NMN altered CS activity and 
FASN, Hadh and Pgc-1α, transcript levels but exercise did not. However, direct measurements of fatty acid oxi-
dation or sirtuin activity would answer this more precisely. It should also be noted that as animals were sacrificed 
18–21 h post exercise, it is possible that some measurements (e.g. mRNA levels) represent a lingering effect of the 
previous exercise session, rather than those of chronic exercise.
As expected, maternal and post-weaning HFD induced glucose intolerance and increased plasma insulin lev-
els. NMN and exercise both partially improved glucose tolerance in the post-weaning HFD groups. The improve-
ment of glucose tolerance in exercise is most likely due to improved insulin sensitivity and glucose uptake, 
especially by skeletal muscle53. In contrast, our data suggest that NMN supplementation may increase clearance 
of glucose from the circulation by increasing plasma insulin levels. It is unclear whether the heightened plasma 
insulin in our cohort is explained by Sirt1-mediated increases in pancreatic islet beta cell mass54 or by increased 
Sirt1-mediated insulin secretion, as NMN was administered 4 hours prior to sacrifice.
We found that 18 days of NMN supplementation had similar beneficial effects to 9 weeks of exercise in a 
mouse model of maternal obesity. The two interventions lowered body weights to the same degree (Table 2) thus 
the differential effects cannot be attributed to indirect influence of body weight. Few studies to date have exam-
ined longer term NMN treatment; in a mouse model of aging 12 months NMN treatment improved a variety of 
age-associated phenotypes including energy metabolism, eye function, bone density and immune function with 
no evidence of toxicity44. We are currently investigating the impact of longer term NMN treatments in the context 
of diet-induced and maternal obesity.
Our results also suggest that improved fat metabolism in liver due to post-weaning NMN supplementation 
and exercise are significant contributors to the overall improvements in adiposity. The interventions appeared 
to exert the most benefits in the offspring that were most metabolically challenged, i.e. the HFD consuming 
Figure 3. Effect of NMN and exercise on expression of genes involved in fat transport, synthesis and 
β-oxidation in liver. Data are shown as mean ± SEM, n = 9–10 per group. The first letter represents maternal 
and second letter represents post-weaning diet; chow (C) or HFD (H); the third letter represents intervention; 
sedentary (S), exercise (X) or NMN (N). Data are presented as fold changes compared to the CCS group. 
To investigate the effects of post-weaning diets and intervention (exercise and NMN) on mRNA expression 
of Cd36 (A), Fasn (B), Acc1 (C), Acc2 (D), Pparg (E), Mpc1 (F), Hadh (G) of the offspring of obese mothers 
consuming chow or HFD, HCS, HCX, HCN and HHS, HHX, HHN were compared by separate two-way 
ANOVAs. The significant effects are: ***P < 0.001 overall post-weaning diet effect. #P < 0.01 and ###P < 0.001 
overall intervention effect. XP < 0.05 and XXXP < 0.001 simple main effect of exercise. ^P < 0.05; ^^P < 0.01 and 
^^^P < 0.01 simple main effect of NMN.
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offspring of obese females. This supports the suitability of NMN for use in reversing metabolic dysfunction linked 
to programming, as well those induced by an individual’s lifestyle. Mechanistically, there are significant differ-
ences in the changes induced by exercise and NMN supplementation, which may be due to the latter increasing 
NAD+ concentrations in liver and consequently stimulating sirtuin activity.
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